Trial Profile
Divalproex Sodium ER in Adult Autism
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jun 2018
Price :
$35
*
At a glance
- Drugs Valproate semisodium (Primary)
- Indications Autistic disorder
- Focus Therapeutic Use
- 29 May 2018 Status changed from recruiting to completed.
- 24 Mar 2009 Additional lead investigator identified as reported by ClinicalTrials.gov.
- 26 Nov 2005 New trial record.